Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-positive viable T cells/kg).: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lupus | 1 |
| Lupus Nephritis | 1 |
| REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS | 1 |
Recruiting trials involving Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-positive viable T cells/kg).
Common questions
How many recruiting trials involve Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-positive viable T cells/kg).?
1 recruiting trial across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.